Improving Alzheimer's disease immunotherapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40773574.
- Also identified by DOI 10.1126/science.adz8959.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A modified antibody targeting amyloid-β reduces adverse events and increases efficacy in a mouse model.
Medical subject headings
- Alzheimer Disease
- Amyloid beta-Peptides
- Immunotherapy
- Antibodies, Monoclonal, Humanized